• Corpus ID: 37328346

Evaluation and treatment of endometriosis.

@article{Schrager2013EvaluationAT,
  title={Evaluation and treatment of endometriosis.},
  author={Sarina B. Schrager and Julianne Falleroni and Jennifer Y. C. Edgoose},
  journal={American family physician},
  year={2013},
  volume={87 2},
  pages={
          107-13
        }
}

• S. Schrager, Julianne Falleroni, J. Edgoose
• Published 15 January 2013
• Medicine
• American family physician

Endometriosis, which affects up to 10 percent of reproductive-aged women, is the presence of endometrial tissue outside of the uterine cavity. It is more common in women with pelvic pain or infertility (25 to 40 percent and 70 to 90 percent, respectively). Some women with endometriosis are asymptomatic, whereas others present with symptoms such as debilitating pelvic pain, dysmenorrhea, dyspareunia, and decreased fertility. Diagnosis of endometriosis in primary care is predominantly clinical. Initial treatment includes common agents used for primary dysmenorrhea, such as nonsteroidal anti-inflammatory drugs, combination estrogen/progestin contraceptives, or progestin-only contraceptives. There is some evidence that these agents are helpful and have few adverse effects. Referral to a gynecologist is necessary if symptoms persist or the patient is unable to become pregnant. Laparoscopy is commonly used to confirm the diagnosis before additional treatments are pursued. Further treatments include gonadotropin-releasing hormone analogues, danazol, or surgical removal of ectopic endometrial tissue. These interventions may control symptoms more effectively than initial treatments, but they can have significant adverse effects and limits on duration of therapy.